Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

35.340
-1.380-3.76%
Volume:18.34M
Turnover:648.44M
Market Cap:214.30B
PE:32.57
High:36.620
Open:36.060
Low:35.000
Close:36.720
52wk High:43.939
52wk Low:27.882
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:1.06
T/O Rate:0.30%
Dividend:0.49
Dividend Rate:1.40%
EPS(LYR):1.085
ROE:19.40%
ROA:9.08%
PB:4.86
PE(LYR):32.57
PS:11.55

Loading ...

CLSA Maintains Positive Rating on Hansoh Pharma, Raises Price Target to HK$42

Deep News
·
Jul 28

Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$37.24 From HK$38, Keeps at Neutral

MT Newswires Live
·
Jul 27

Oral Cyclic Peptides Enter Validation Phase, Opening a Multi-Billion Dollar Therapeutic Arena

Stock News
·
Jul 22

Hansoh Pharmaceutical Group Stock Slips 1.5% in Hong Kong

Dow Jones
·
Jul 21

Movement Alert|Hansoh Pharmaceutical Declines 3.33% in Regular Trading, Trading at HK$31.98

Market Focus
·
Jul 21

Hansoh Pharmaceutical Group Stock Rises 4.0% in Hong Kong

Dow Jones
·
Jul 20

Movement Alert|Hansoh Pharmaceutical Rises 3.08% in Regular Trading, Pharmaceutical Sector Recovery Coupled with Multiple Pipeline Catalysts

Market Focus
·
Jul 20

Hansoh Pharmaceutical Group Stock Falls 4.1% in Hong Kong

Dow Jones
·
Jul 17

Movement Alert|Hansoh Pharmaceutical Falls 3.08% in Regular Trading, Broad Pharmaceutical Sector Weakness Drags Shares Lower

Market Focus
·
Jul 17

Movement Alert|Hansoh Pharmaceutical Rises 3.17% in Regular Trading, Multiple Catalysts Including Avere-NextCure Merger and HS-20093 Phase III Success Drive Momentum

Market Focus
·
Jul 16

Hansoh Pharma Earns MSCI ESG AAA Rating

Reuters
·
Jul 15

HANSOH PHARMA Shares Surge on Global Licensing Deal and Merger Announcement

Stock News
·
Jul 15

Movement Alert|Hansoh Pharmaceutical Rises 3.5% in Regular Trading, Subsidiary Avere to Merge into Nasdaq-Listed NextCure

Market Focus
·
Jul 15

Hansoh Pharmaceutical Discloses Transactions with Avere Therapeutics

Reuters
·
Jul 14

Hansoh Pharma Licenses Oral IL-23 Drug Hs-20118 to Avere in Deal Worth up to USD 2.3 Billion

Reuters
·
Jul 14

Hansoh-backed Avere Agrees to Merge with Nextcure in All-stock Deal

Reuters
·
Jul 14

Hansoh Pharmaceutical - Avere Therapeutics to Merge into Nextcure Under Merger Agreement Signed July 14, 2026

THOMSON REUTERS
·
Jul 14

Hansoh Pharmaceutical - Combined Entity to Operate as Avere Therapeutics, and Trade as Avrx

THOMSON REUTERS
·
Jul 14

Hansoh Pharmaceutical - Hanshoh Pharma to Hold over 30% but Under 40% of Combined Entity Post-merger

THOMSON REUTERS
·
Jul 14

Hansoh Pharmaceutical Group Stock Rises 1.8% in Hong Kong

Dow Jones
·
Jul 13